The Latest
FDA Approves Sprinkle Formulation of Rosuvastatin
Crizanlizumab Granted Priority Review for Sickle Cell Pain Crises Prevention
Recall Of Multiple Rx, OTC Ophthalmic Products Announced
Contrast Agent Gadavist Approved for Use in Cardiac MRI
E-Cigarette Restrictions May Up Combustible Cigarette Use
AirDuo Digihaler, a Digital Maintenance Asthma Inhaler Therapy, Gets FDA Approval
RNAi Therapy Gets Breakthrough Status for Primary Hyperoxaluria Type 1
FDA Rejects Dapagliflozin sNDA for Type 1 Diabetes
Umibecestat Alzheimer Disease Prevention Trials Discontinued
MPR ARTICLES
